Articles from Sterne, Kessler, Goldstein & Fox

Sterne, Kessler, Goldstein & Fox and Thomson Reuters today announced a co-development partnership that has produced the first attorney-built AI workflow within CoCounsel Legal. The Patent Claim Eligibility Analyzer is a new AI tool designed to assist patent litigators with Section 101 patent eligibility analysis.

Sterne, Kessler, Goldstein & Fox proudly announces the election of three new directors effective January 1, 2026. The newly promoted directors are Brian Dudley, Brady Gleason, and Melissa Haapala.

Sterne, Kessler, Goldstein & Fox announced today that Byron L. Pickard will serve as the firm’s new Managing Director. He succeeds Michael B. Ray, who has served as Managing Director of the firm since 2007 and will now assume the role of firm Chair.

Sterne, Kessler, Goldstein & Fox won a $9.5 million jury verdict on behalf of Mallinckrodt Pharmaceuticals in a patent infringement lawsuit filed in the U.S. District Court for the District of Delaware over Mallinckrodt’s INOmax (nitric oxide for inhalation) drug product and associated nitric oxide delivery device.

Sterne, Kessler, Goldstein & Fox announced today that Jacqueline (Jackie) D. Wright Bonilla, former Deputy Chief Administrative Patent Judge at the Patent Trial and Appeal Board (PTAB), has joined the firm as a director in the Biotechnology & Chemical and Trial & Appellate Practice Groups.

Sterne, Kessler, Goldstein & Fox is pleased to announce that its client, RoboticVISION Tech, Inc. (RVT), has settled its lawsuits against its competitors, ABB Inc. and ABB Ltd.

Sterne, Kessler, Goldstein & Fox proudly announces the election of five new directors, effective January 1, 2025. The newly promoted attorneys are Jennifer Meyer Chagnon, Dohm Chankong, Joseph Kim, Steve Pappas, and Tyler Tassone.